trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Glucocerebrosidase (GBA) is a lysosomal enzyme that results in Gaucher's disease when deficient due to mutations.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
9 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Glucocerebrosidase (GBA) is a lysosomal enzyme that results in Gaucher's disease when deficient due to mutations?

Yes. Glucocerebrosidase is a lysosomal enzyme encoded by the GBA1 gene, and deficiencies caused by mutations in this gene result in Gaucher disease.

Verdict: SUPPORTED · 9 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently confirm that mutations in the GBA/GBA1 gene lead to a deficiency in the lysosomal enzyme glucocerebrosidase, which causes Gaucher disease. There are no papers contradicting this established genetic and biochemical fact.

Evidence for · 9
2024
States that Gaucher disease results from biallelic mutations in the GBA1 gene causing deficient glucocerebrosidase activity.
Get citation
A, K., T, C., E, S., & TU, H. (2024). Advancements in Viral Gene Therapy for Gaucher Disease.. doi.org. https://doi.org/10.3390/genes15030364

See more details
More for · 8
2025
Confirms glucocerebrosidase deficiency as the underlying cause of Gaucher disease pathophysiology.
Get citation
F, C. & MG, B. (2025). Gaucher disease, state of the art and perspectives.. doi.org. https://doi.org/10.1111/joim.20114

2025
Indicates that Gaucher disease type 1 is caused by GBA1 mutations leading to deficient β-glucocerebrosidase enzyme activity.
Get citation
F, C., CJ, M., B, L., T, D., JM, J., M, C., C, C., K, K., G, T., E, C., E, S., E, S., S, S., IM, Y., J, P., J, K., N, N., P, K., S, C., Y, S., AP, D., R, S., AC, N., & R, C. (2025). FLT201, a novel liver-directed AAV gene therapy candidate for Gaucher disease type 1.. doi.org. https://doi.org/10.1016/j.ymthe.2025.05.003

2026
Notes that biallelic mutations in GBA1 encode the lysosomal enzyme glucocerebrosidase and are causative for Gaucher disease.
Get citation
R, W., T, H., N, H., & D, C. (2026). Interplay of GBA1 with lysosomal dysfunction and inflammation in Parkinson's disease.. doi.org. https://doi.org/10.4103/nrr.nrr-d-25-01082

2020
Identifies Gaucher's disease as a lysosomal storage disorder caused by enzyme deficiency from GBA mutations.
Get citation
Önal, G., Gümüş, E., Demir, H., Yüce, A., & (Emre), S. D. (2020). Molecular genetic analysis of Turkish Gaucher's disease patients reveals three novel variants in Glucocerebrosidase (GBA) gene. doi.org. https://doi.org/10.1016/j.mgene.2020.100725

2026
Explains that Gaucher disease is a lysosomal storage disorder caused by glucocerebrosidase gene mutations leading to acid β-glucosidase deficiency.
Get citation
F, C., S, L., & M, S. (2026). Glucosylsphingosine (Lyso-Gb1): An Update on Its Use as a Biomarker in Gaucher Disease.. doi.org. https://doi.org/10.3390/ijms27041705

2025
Describes Gaucher disease as an autosomal recessive lysosomal storage disorder caused by GBA1 mutations leading to glucocerebrosidase deficiency.
Get citation
DG, P., G, P., T, D., S, S., SM, J., & P, J. (2025). Genotype Meets Phenotype: Unraveling Gaucher's Genetic Landscape in the Indian Population.. doi.org. https://doi.org/10.7759/cureus.92009

2026
Highlights that Gaucher disease stems from deficient glucocerebrosidase activity and lysosomal lipid accumulation.
Get citation
A, C., O, M., & G, C. (2026). Gaucher disease: the hematologist's perspective of a multisystemic disorder.. doi.org. https://doi.org/10.1007/s00277-026-06977-3

2026
Confirms that biallelic mutations in GBA1, which encodes glucocerebrosidase, cause Gaucher disease.
Get citation
V, F., G, D. R., V, F., A, C., F, C., & V, S. (2026). The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancer.. doi.org. https://doi.org/10.1038/s41420-026-03046-6

What does the evidence say?

The retrieved papers consistently confirm that mutations in the GBA/GBA1 gene lead to a deficiency in the lysosomal enzyme glucocerebrosidase, which causes Gaucher disease. There are no papers contradicting this established genetic and biochemical fact.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work